Riskpilot← Back to searchSign inGet full accessRØA ØRE NESE HALS AS
ASActiveOrg 922329893Tore Hals Mejdells vei 8, 0751 OsloGeneral medical practice activities · NACE 8621Est. 20196 employees
Revenue 2025
NOK 7,8M
+1% vs 2024
EBITDA margin
1.6%
+3% vs 2024
Equity ratio
25.3%
Financial strength
Net profit 2025
NOK -71K
+7% vs 2024
| Revenue | NOK 7,8M | +1% |
| EBITDA | NOK 123K | +3% |
| Net profit | NOK -71K | +7% |
| Total assets | NOK 2,8M | +30% |
| Equity | NOK 707K | -9% |
| Employees | 6 | — |
Legal name
RØA ØRE NESE HALS AS
Org number
922329893
Legal form
Aksjeselskap
NACE code
8621 · General medical practice activities
Founded
6. mars 2019
Share capital
NOK 60 000
Employees
6 (FTE)
VAT registered
No
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Styrets leder alene.
Company purpose
Allmenn legepraksis samt det som naturlig står i forbindelse med dette.
Address
Tore Hals Mejdells vei 8, 0751 Oslo
Phone
+4722131500
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 12 775 | 16 395 | 8 853 | 7 688 | 7 753 |
| Staff expenses | −3 267 | −4 595 | −5 263 | −5 413 | −5 560 |
| EBITDA | 3 427 | 8 018 | 1 243 | 120 | 123 |
| Depreciation & amort. | −39 | −173 | −214 | −214 | −214 |
| EBIT | 3 388 | 7 844 | 1 029 | −94 | −90 |
| Net financials | −18 | −4 | −13 | −0 | −0 |
| Profit before tax | 3 370 | 7 840 | 1 016 | −94 | −90 |
| Tax | 743 | 1 714 | 227 | −18 | −20 |
| Net profit | 2 627 | 6 126 | 790 | −76 | −71 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 4 327 | 6 135 | 1 949 | 2 159 | 2 800 |
| Equity | 64 | 65 | 854 | 778 | 707 |
| Long-term debt | 0 | 21 | 11 | 0 | 0 |
| Short-term debt | 4 237 | 6 049 | 1 084 | 1 381 | 2 092 |
| Total debt | 4 262 | 6 070 | 1 095 | 1 381 | 2 092 |
EBITDA margin
1.6%
This company
15.8%
Market median
-90% vs market
20212025
Equity ratio
25.3%
This company
38.2%
Market median
-34% vs market
20212025
Return on equity
-10.0%
This company
18.4%
Market median
-154% vs market
20212025
Net profit margin
-0.9%
This company
8.1%
Market median
-111% vs market
20212025
Asset turnover
2.77×
This company
1.12×
Market median
+147% vs market
20212025
Debt / equity
2.96×
This company
0.62×
Market median
-377% vs market
20212025
- Annual report 2025Filed via Brønnøysundsregistrene · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
ED Deputy Member | Deputy Member | 2021 |
HK Deputy Member | Deputy Member | 2021 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Board of Directors | 2024 | |
| Chairman | 2024 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 80% | 80% | 2024 | |
| Company | 20% | 20% | 2024 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Steinsolid As
RØA ØRE NESE HALS AS Board members of RØA ØRE NESE HALS AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Eivind Devold Steinsvik | Deputy Member | 0 companies |
| Helena Kyttari Djupesland | Deputy Member | 0 companies |
| Per Gisle Djupesland | Board of Directors | 0 companies |
| Eivind Andreas Svaboe Steinsvik | Chairman | 0 companies |